EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 104 filers reported holding EVOFEM BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -96.3% | 2,145 | -97.0% | 0.00% | – |
| Q4 2021 | $27,000 | -20.6% | 72,260 | +55.6% | 0.00% | – |
| Q3 2021 | $34,000 | +277.8% | 46,432 | +441.4% | 0.00% | – |
| Q2 2021 | $9,000 | -79.1% | 8,577 | -64.4% | 0.00% | – |
| Q1 2021 | $43,000 | -51.7% | 24,120 | -34.8% | 0.00% | – |
| Q4 2020 | $89,000 | +74.5% | 37,009 | +70.8% | 0.00% | – |
| Q3 2020 | $51,000 | -36.2% | 21,667 | -22.6% | 0.00% | – |
| Q2 2020 | $80,000 | +73.9% | 27,992 | +225.5% | 0.00% | – |
| Q1 2020 | $46,000 | -58.2% | 8,599 | -51.8% | 0.00% | – |
| Q4 2019 | $110,000 | +93.0% | 17,834 | +59.8% | 0.00% | – |
| Q3 2019 | $57,000 | +200.0% | 11,163 | +286.9% | 0.00% | – |
| Q2 2019 | $19,000 | +1800.0% | 2,885 | +766.4% | 0.00% | – |
| Q1 2019 | $1,000 | -95.5% | 333 | -93.8% | 0.00% | – |
| Q4 2018 | $22,000 | +2100.0% | 5,376 | +1514.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 333 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 333 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Taylor Wealth Management Partners | 545,413 | $954,000 | 0.35% |
| HEARTLAND ADVISORS INC | 2,655,400 | $4,647,000 | 0.29% |
| Maven Securities LTD | 2,750,000 | $4,826,000 | 0.22% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 150,000 | $263,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 265,286 | $464,000 | 0.08% |
| GREAT LAKES ADVISORS, LLC | 1,697,052 | $2,970,000 | 0.05% |
| CAAS CAPITAL MANAGEMENT LP | 2,335,305 | $4,087,000 | 0.04% |
| Virtu Financial LLC | 174,447 | $305,000 | 0.02% |
| Game Plan Financial Advisors, LLC | 18,500 | $33,000 | 0.02% |
| Baker Brothers Advisors | 2,697,110 | $4,720,000 | 0.02% |